Annual Total Long Term Liabilities
$84.62 M
+$14.82 M+21.23%
31 December 2023
Summary:
Centessa Pharmaceuticals annual total long term liabilities is currently $84.62 million, with the most recent change of +$14.82 million (+21.23%) on 31 December 2023. During the last 3 years, it has risen by +$59.10 million (+231.56%). CNTA annual total long term liabilities is now -74.40% below its all-time high of $330.54 million, reached on 01 June 2019.CNTA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$84.17 M
-$953.00 K-1.12%
30 September 2024
Summary:
Centessa Pharmaceuticals quarterly total long term liabilities is currently $84.17 million, with the most recent change of -$953.00 thousand (-1.12%) on 30 September 2024. Over the past year, it has increased by +$1.15 million (+1.39%). CNTA quarterly long term liabilities is now -25.80% below its all-time high of $113.44 million, reached on 31 December 2021.CNTA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTA Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +21.2% | +1.4% |
3 y3 years | +231.6% | +148.1% |
5 y5 years | -74.4% | - |
CNTA Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -25.4% | +231.6% | -25.8% | +148.1% |
5 y | 5 years | -74.4% | +231.6% | -25.8% | +267.4% |
alltime | all time | -74.4% | -25.8% | +267.4% |
Centessa Pharmaceuticals Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $84.17 M(-1.1%) |
June 2024 | - | $85.13 M(-0.5%) |
Mar 2024 | - | $85.57 M(+1.1%) |
Dec 2023 | $84.62 M(+21.2%) | $84.62 M(+1.9%) |
Sept 2023 | - | $83.02 M(+0.7%) |
June 2023 | - | $82.45 M(+1.9%) |
Mar 2023 | - | $80.91 M(+15.9%) |
Dec 2022 | $69.80 M(-38.5%) | $69.80 M(+2.3%) |
Sept 2022 | - | $68.24 M(+1.2%) |
June 2022 | - | $67.44 M(-9.9%) |
Mar 2022 | - | $74.84 M(-34.0%) |
Dec 2021 | $113.44 M | $113.44 M(+234.3%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $33.93 M(0.0%) |
June 2021 | - | $33.93 M(+48.1%) |
Mar 2021 | - | $22.91 M |
Dec 2020 | $25.52 M(-91.9%) | - |
June 2020 | $314.99 M(-4.7%) | - |
June 2019 | $330.54 M(+53.6%) | - |
June 2018 | $215.23 M(-17.7%) | - |
June 2017 | $261.39 M(-12.7%) | - |
June 2016 | $299.36 M(+54.1%) | - |
June 2015 | $194.29 M(>+9900.0%) | - |
May 2015 | $0.00(0.0%) | - |
May 2014 | $0.00 | - |
FAQ
- What is Centessa Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Centessa Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Centessa Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of CNTA is $84.62 M
What is the all time high annual total long term liabilities for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual total long term liabilities is $330.54 M
What is Centessa Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, CNTA annual total long term liabilities has changed by +$14.82 M (+21.23%)
What is Centessa Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of CNTA is $84.17 M
What is the all time high quarterly long term liabilities for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly total long term liabilities is $113.44 M
What is Centessa Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, CNTA quarterly total long term liabilities has changed by +$1.15 M (+1.39%)